Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression

Overview of attention for article published in OncoImmunology, June 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter: 37 X users
patent: 1 patent

facebook: 3 Facebook pages

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

CANNABINOIDS AND USES THEREOF IN TREATMENT OF A DISEASE

Application WO-2024038440-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.